Aftovaxpur DOE

RSS

Foot-and-mouth disease vaccine (inactivated) (multistrain: 1-3 strains out of set of 8)

Authorised
This medicine is authorised for use in the European Union.

Overview

Aftovaxpur DOE is a vaccine used to vaccinate cattle, sheep and pigs from two weeks of age against foot-and-mouth disease. Foot-and-mouth disease affects cloven-hoofed animals and causes fever, followed by blisters on the inside of the mouth and on the feet which may rupture and lead to lameness. Aftovaxpur DOE contains up to three strains of inactivated (killed) foot-and-mouth disease virus. These strains belong to four different serotypes (groups) of the virus known as O, A, Asia 1 and SAT2, and are selected, depending on the epidemiological need, from the following eight strains: O1 Manisa, O1 BFS, O Taiwan 3/97, A22 Iraq, A24 Cruzeiro, A Turkey 14/98, Asia 1 Shamir and SAT2 Saudi Arabia.

This EPAR was last updated on 11/03/2019

Authorisation details

Product details
Name
Aftovaxpur DOE
Agency product number
EMEA/V/C/002292
Active substance
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia  ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063.
International non-proprietary name (INN) or common name
Foot-and-mouth disease vaccine (inactivated) (multistrain: 1-3 strains out of set of 8)
Species
  • Pigs
  • Cattle
  • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AA04
Publication details
Marketing-authorisation holder
Merial
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
15/07/2013
Contact address

29 Avenue Tony Garnier
69007 Lyon
France

Product information

12/12/2018 Aftovaxpur DOE - EMEA/V/C/002292 - II/0009

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

Assessment history

How useful was this page?

Add your rating